Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of AJU-C715 and C715R in Healthy Adults
NCT07581028Phase 1Completed
- Sponsor
- AJU PHARM Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in hypercholesterolemia and dyslipidemia (2 arms), sponsored by AJU PHARM Co., Ltd. Primary endpoints: Area Under the Curve from time zero to the last quantifiable concentration and Maximum Observed Plasma Concentration. Started Aug 2026; status: completed.
02
Conditions
hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on NCT07581028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07581028.